Actively Recruiting
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Led by University of California, San Francisco · Updated on 2025-07-23
70
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
CONDITIONS
Official Title
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients initially seen at Zuckerberg San Francisco General Hospital eye clinic and approved for cataract surgery in both eyes
- Patients 18 years of age or older
- Patients who choose to have cataract surgery in both eyes
You will not qualify if you...
- Patients needing cataract surgery in both eyes on the same day
- History of endophthalmitis, advanced glaucoma, steroid-related eye pressure increase, prior eye surgery, or recent retinal swelling
- Allergy or intolerance to penicillin or cephalosporin antibiotics
- Patients needing combined cataract and other eye specialty surgery on the same day
- Pregnant or breastfeeding patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG)
San Francisco, California, United States, 94110
Actively Recruiting
Research Team
S
Sriranjani Padmanabhan, MD
CONTACT
N
Nicole Xin, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here